Improvement in microvascular reflow and reduction of infarct size with adenosine in patients undergoing primary coronary stenting.

[1]  M. Claeys,et al.  Effect of intracoronary adenosine infusion during coronary intervention on myocardial reperfusion injury in patients with acute myocardial infarction. , 2004, The American journal of cardiology.

[2]  Hiroshi Ito,et al.  Myocardial contrast echocardiography with a new calibration method can estimate myocardial viabilityin patients with myocardial infarction , 2004 .

[3]  G. Rousseau,et al.  Post-Ischemic Cardioprotection by A2A Adenosine Receptors: Dependent of Phosphatidylinositol 3-Kinase Pathway , 2004, Journal of cardiovascular pharmacology.

[4]  Courtney M. Lappas,et al.  Activation of A2A adenosine receptors inhibits expression of α4/β1 integrin (very late antigen‐4) on stimulated human neutrophils , 2004 .

[5]  R. Gibbons,et al.  A randomized, double-blinded, placebo-controlled, dose-ranging study measuring the effect of an adenosine agonist on infarct size reduction in patients undergoing primary percutaneous transluminal coronary angioplasty: the ADMIRE (AmP579 Delivery for Myocardial Infarction REduction) study. , 2003, American heart journal.

[6]  A. Sollevi,et al.  Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis , 2003, European Journal of Clinical Pharmacology.

[7]  H. Samady,et al.  Detection of myocardial viability by contrast echocardiography in acute infarction predicts recovery of resting function and contractile reserve. , 2003, Journal of the American College of Cardiology.

[8]  S. Kaul,et al.  Noninvasive Prediction of Ultimate Infarct Size at the Time of Acute Coronary Occlusion Based on the Extent and Magnitude of Collateral-Derived Myocardial Blood Flow , 2001, Circulation.

[9]  J. Linden,et al.  Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A2A receptor agonists , 2001 .

[10]  J. Linden Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. , 2001, Annual review of pharmacology and toxicology.

[11]  R. Testa,et al.  Beneficial effects of intracoronary adenosine as an adjunct to primary angioplasty in acute myocardial infarction. , 2000, Circulation.

[12]  J Sklenar,et al.  Assessment of resting perfusion with myocardial contrast echocardiography: theoretical and practical considerations. , 2000, American heart journal.

[13]  R. Califf,et al.  Myocardial Infarction Adenosine as an Adjunct to Thrombolytic Therapy for Acute Myocardial Infarction , 1999 .

[14]  U. Deligonul,et al.  The clinical implications of no reflow demonstrated with intravenous perfluorocarbon containing microbubbles following restoration of Thrombolysis In Myocardial Infarction (TIMI) 3 flow in patients with acute myocardial infarction. , 1998, The American journal of cardiology.

[15]  A R Jayaweera,et al.  Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. , 1998, Circulation.

[16]  D. Boyle,et al.  Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors. , 1997, Journal of immunology.

[17]  Y. Taniyama,et al.  Myocardial perfusion patterns related to thrombolysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. , 1996, Circulation.

[18]  S. Kaul,et al.  Characterization of Spatial Patterns of Flow Within the Reperfused Myocardium by Myocardial Contrast Echocardiography Implications in Determining Extent of Myocardial Salvage , 1993, Circulation.

[19]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[20]  R. Wilson,et al.  Effects of adenosine on human coronary arterial circulation. , 1990, Circulation.

[21]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[22]  W. Roberts,et al.  Comparison of amount of extent of coronary narrowing by atherosclerotic plaque and of myocardial scarring at necropsy in anterior and posterior healed transmural myocardial infarction. , 1982, Circulation.